Furthermore, ROR2 expression was observed in four patient samples harboring alternative ALK fusions with other or unknown ALK partners (Fig. 6G and Table 1), thus indicating that ROR2 is a genuine marker of ALK+ ALCL regardless of the fusion partner. Here, ALK is linked to anaplastic large cell lymphoma.